Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS)

Circulation

Volumn 98, Issue 20, 1998, Pages 2126-2132

  Urban, Philip ^a   Macaya, Carlos ^b   Rupprecht, Hans Jürgen ^c   Kiemeneij, Ferdinand ^d   Emanuelsson, Hakan ^e   Fontanelli, Alessandro ^f   Pieper, Michael ^g   Wesseling, Thea ^h   Sagnard, Luc ^h  

^a LA TOUR HOSPITAL   (Switzerland)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^g Herz Zentrum Bodensee   (Switzerland)

^h SANOFI   (France)

Author keywords

Angioplasty; Anticoagulants; Platelets; Stents; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ADULT; AGED; ALLERGY; ANGIOPLASTY; ARTICLE; BLEEDING; CHOLECYSTITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEPATITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; STENT; THROMBOSIS;

EID: 0032542028     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.20.2126     Document Type: Article

References (34)

1. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987;316:701-706.
2. Sigwart U, Urban P, Golf S, Kaufmann U, Imbert C, Fischer A, Kappenberger L. Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation. 1988;78:1121-1127.
3. Roubin GS, Cannon AD, Agrawal SK, Macander PJ, Dean LS, Baxley WA, Breland J. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation. 1992;85:916-927.
4. Serruys PW, De Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel M-A, for the Benestent Study Investigators. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.
5. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein P, Fish D, Colombo A, Brinker J, Moses J, Shakrovich A, Hischfeld J, Bailey S, Ellis S, Rake R, Goldberg S. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:539-541.
6. Serruys PW, Strauss BH, Beatt KJ, Bertrand ME, Puel J, Rickards A, Meier B, Goy JJ, Vogt P, Kappenberger L, Sigwart U. Angiographic follow-up after placement of a self-expanding coronary artery stent. N Engl J Med. 1991;324:13-17.
7. de Feyter PJ, DeScheerder I, van den Brand M, Laarman GJ, Suryapranata H, Serruys PW. Emergency stenting for refractory acute coronary artery occlusion during coronary artery angioplasty. Am J Cardiol. 1990;66:1147-1150.
8. Haude M, Erbel R, Straub U, Dietz U, Meyer J. Short and long term results after intracoronary stenting in human coronary arteries: monocentre experience with the balloon-expandable Palmaz-Schatz stent. Br Heart J. 1991;66:337-345.
9. Herrmann HC, Buchbinder M, Clemen MW, Fischman D, Goldberg S, Leon MB, Schatz RA, Teirstein P, Walker CM, Hirshfeld JW. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty. Circulation. 1992;86:812-819.
10. Nath FC, Muller DWM, Ellis SG, Rosenschein U, Chapekis A, Quain L, Zimmerman C, Topol EJ. Thrombosis of a flexible coil stent: frequency, predictors and clinical outcome. J Am Coll Cardiol. 1993;21:622-627.
11. Kiememeij F, Laarman GJ, van der Wieken R, Suwarganda J. Emergency coronary stenting with the Palmaz-Schatz stent for failed transluminal coronary angioplasty: results of a learning phase. Am Heart J. 1993;126: 23-31.
12. Haude M, Erbel R, Issa H, Straub U, Rupprecht HJ, Treese N, Meyer J. Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Am Heart J. 1993;126:15-22.
13. Barragan P, Sainsous J, Silvestri M, Bouvier JL, Comet B, Simeoni JB, Charmasson C, Bremondy M. Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. Cathet Cardiovasc Diagn. 1994;32:133-138.
14. Karillon GJ, Morice MC, Benveniste E, Bunouf P, Aubry P, Cattan S, Chevalier P, Commeau P, Cribier A, Eiferman C, Grollier G, Guerin Y, Henry M, Lefevre T, Livarek B, Louvard Y, Marco J, Makowski S, Monassier JP, Pernes JM, Rioux P, Spaulding C, Zemour G. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatdet therapy. Circulation. 1996;94:1519-1527.
15. Lablanche JM, McFadden EP, Bonnet JL, Grollier G, Danchin N, Bedossa M, Leclercq C, Vahanian A, Bauters C, van Belle E, Bertrand ME. Combined antiplatelet therapy with ticlopidine and aspirin. Eur Heart J. 1996;17:1373-1380.
16. Van Belle E, McFadden EP, Lablanche JM, Bauters C, Hamon M, Bertrand ME. Two-pronged antiplatelet therapy with aspirin and ticlopidine without systemic anticoagulation: an alternative therapeutic strategy after bailout stent implantation. Coron Artery Dis. 1995;6: 341-345.
17. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione G, Goldberg SL, Tobis SL. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676-1688.
18. Serruys PW, Emanuelsson H, van der Giessen W, Lunn AC, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Suryapranata H, Legrand V, Goy JJ, Materne P, Bonnier H, Morice MC, Fajadet J, Belardi J, Colombo A, Garcia E, Ruygrok P, de Jaegere P, Morel MA, for the Benestent-II Study Group. Heparin-coated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-II pilot study. Circulation. 1996;93: 412-422.
19. Baim DS, Carozza JP. Stent thrombosis: closing in on the best preventive treatment. Circulation. 1997;95:1098-1100.
20. Leon MB, Baim DS, Gordon P, Giambortolomei A, Williams DO, Diver DJ, Senerchia C, Fitzpatrick M, Popma JJ, Kuntz RE. Clinical and angiographic results from the stent anticoagulation regimen study (STARS). Circulation. 1996;94(suppl I):I-685. Abstract.
21. Hall P, Nakamura FJ, Maiello L, Itoh A, Blengino S, Martini G, Ferraro M, Colombo A. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin alone after successful intravascular ultrasound-guided stent implantation. Circulation. 1996;93:215-222.
22. Schömig A, Neumann FJ, Kastrati A, Schulen H, Blasini R, Hadamitsky M, Walker H, Zitzman-Roth EM, Richard G, Alt E, Schmitt C, Ulm K. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 1996;334: 1084-1089.
23. Bertrand M, Legrand V, Boland J, Fleck E, Bonnier J, Emanuelsson H, Vrolix M, Missault L, Chierchia S, Casaccia M, Niccoli L, Oto A. Full anticoagulation versus ticlopidine plus aspirin after stent implantation: a randomized multicenter European study: the FANTASTIC trial. Circulation. 1996;94(suppl I):I-685. Abstract.
24. Pepine CJ, Holmes DR, Block PC, Brinker JA, Mark DB, Mullins CE, Nissen SE, Topol EJ, Williams DO. American College of Cardiology Expert Consensus document: coronary artery stents. J Am Coll Cardiol. 1996;28:782-794.
25. Keighley CS, Urban P, Killer I, Chatelain P, Morandini E, Verin V, Rutishauser W. Palmaz-Schatz coronary stent implantation without intravascular ultrasound and without subsequent anticoagulation: clinical outcome. J Invas Cardiol. 1996;8:185-190.
26. Popma JJ, Lansky AJ, Mintz GS, Hong MK, Brahimi A, Burwell N, Leon MB. Antithrombotic therapy after stent deployment. J Invas Cardiol. 1996;8(suppl B):34B-42B.
27. Rodriguez A, Ambrose JA. Do we require a cure for "stentmania?" J Am Coll Cardiol. 1996;28:827-829.
28. Nakamura S, Hall P, Gaglione A. High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation. J Am Coll Cardiol. 1997;29:21-27.
29. Tobis JM. Not all stents are created equal. Cathet Cardiovasc Diagn. 1997;40:265-270.
30. Schulen H, Hadamitzky M, Walter H, Ulm K, Schömig A. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement. Circulation. 1997; 95:2015-2021.
31. Hass WK, Easton JD, Adams Jr HP, Pryse-Phillips W, Molony BA, Anderson S, Kamm B, for the Ticlopidine Aspirin Stroke Study Group. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med. 1989;321: 501-507.
32. Carlson JA, Maesner JE. Fatal neutropenia and thrombocytopenia associated with ticlopidine. Ann Pharmacother. 1994;28:1236-1238.
33. CAPRIE Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events. Lancet. 1996;348: 1329-1339.
34. Muhlstein JB, Karagounis LA, Treehan S, Anderson JL. "Rescue" utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty. J Am Coll Cardiol. 1997;30: 1729-1734.